BioSpace News Archive

Confo Therapeutics, an emerging drug discovery company, today announces the formation of its Scientific Advisory Board (SAB) with four key appointments: Radu Aricescu, Peter Kolb, Graeme Milligan and Jan Steyaert, Founder of Confo Therapeutics, who will serve as Chairman of the SAB.

Danforth Advisors, LLC, the life science industry’s leading resource for operational accounting, finance support and CFO services, today announced newly-established operations in Pittsburgh and Dallas – including C-level advisory and resources spanning the full breadth of a flexible, outsourced finance team.

Tufts Health Plan has added dermatology to its telehealth solution, providing their commercial members with access to a doctor, behavioral health therapist, or dermatologist 24-hours a day, seven days a week by web, phone, or mobile app— whether it be from the comfort of their home or while traveling.

Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases, today announced the company’s support for Rare Disease Day 2019 for patients living with hereditary transthyretin (hATTR) amyloidosis and familial chylomicronemia syndrome (FCS) and their caregivers, including bringing several of them together to participate in a live panel discussion related to their disease.

MGC Diagnostics Corporation (MGCD), through its Medical Graphics and Medisoft subsidiaries, is a global medical technology company dedicated to the delivery of diagnostic solutions for detecting, classifying, and managing cardiorespiratory disease

Ancestry®, the global leader in family history and consumer genomics, announced the release of new, cutting-edge family history research tools and never-before digitized historical records to continue to empower their customers’ ongoing journeys of personal discovery.

Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody’s / BB+ S&P, both stable) announces an exclusive license, supply and distribution agreement with Melinta Therapeutics (Melinta), for Melinta’s intravenous and oral formulations of Baxdela

Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetic eye disease, announces today that it will present at the 9th European Society of Retina Specialists (EURETINA) Winter Meeting, which is being held March 1-2, 2019 in Prague, Czech Republic at the Clarion Congress Hotel.

Amplifon S.p.A., global leader in hearing solutions and services, has moved its North American headquarters from Plymouth, Minn. to Fifth Street Towers, at 150 S. 5th Street, Minneapolis.

Amryt, a revenue generating orphan drug company focused on acquiring, developing & commercialising products that help to improve the lives of patients where there is a high unmet medical need, today announces an update on its pivotal Phase III EASE trial for AP101 as a potential treatment for Epidermolysis Bullosa (“EB”).